Recombinant human adenovirus type 5 (H101) combined with anti-PD-1 monoclonal antibody in the treatment of patients with advanced melanoma with previous immunotherapy failure: A single-site, ...

Human adenovirus type 5 (recombinant) overview Adenovirus Type 5, human recombinant (Oncorine) is a replication selective, recombinant, E1B and partial E3 gene deleted form of human adenovirus type 5, ...

High-Titer Recombinant Adenovirus 26 Vector GMP Manufacturing in HEK 293 Cells with a Stirred Single-Use Bioreactor for COVID-19 Vaccination Purposes Hossein Sedighikamal* ...

SpyBiotech Receives Grant to Advance Novel SpyVector Platform That Improves Efficacy and Boosting Capability of Adenovirus-based Vaccines Against Current and Future Pandemic Viruses ...

Citation: Powers TW, Mullins EK, Zhang K, Binder JJ, Friese O, Runnels HA and Thompson LC (2022) Identification of Recombinant Chimpanzee Adenovirus C68 Degradation Products Detected by AEX-HPLC.

In a recent study posted to the bioRxiv* server, researchers assessed the immunogenicity of the self-developed recombinant adenovirus vector (rAd5) vaccine on macaques. They evaluated the efficacy ...

According to the statistics of Our World in Data, as of September 2, 2021, Recombinant COVID-19 Vaccine (Adenovirus Vector) jointly developed by AstraZeneca and University of Oxford has been ...

Russia's Sputnik V uses recombinant human adenoviruses Ad26 and Ad5 for the first and second doses, respectively. Finally, China's CanSino vaccine uses the recombinant human adenovirus Ad5.

A multitargeted recombinant adenovirus 5 (Ad5) vaccine platform was shown to be safe and clinically active in a phase 1 trial of patients with metastatic castration-resistance prostate cancer. 1,2 ...

The Ad26.COV2.S vaccine is a recombinant, replication-incompetent human adenovirus type 26 vector encoding full-length severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein in ...

In humans, adenovirus infections most commonly cause mild respiratory symptoms, but sometimes, the viruses can cause severe disease; people with compromised immune systems, existing respiratory ...

Adenovirus-based recombinant vaccines are good inducers of cellular immunity (31); however, they may not be optimal for the induction of humoral responses in our experimental setting. Our data ...